Galectin-1-based tumour-targeting for gold nanostructure-mediated photothermal therapy

References

• Pilot Study of AuroLase (tm) Therapy in Refractory and/or Recurrent Tumors of the Head and Neck. 2008–2014. Available from: https://clinicaltrials.gov/ct2/show/NCT00848042 [last accessed 31 Jul 2016].
   Google Scholar
• Efficacy Study of AuroLase Therapy in Subjects With Primary and/or Metastatic Lung Tumors. 2012–2014. Available from: https://www.clinicaltrials.gov/ct2/show/NCT01679470 [last accessed 31 Jul 2016].
   Google Scholar
• Libutti SK, Paciotti GF, Byrnes AA, et al. (2010). Phase I and pharmacokinetic studies of CYT-6091, a novel PEGylated colloidal gold-rhTNF nanomedicine. Clin Cancer Res 16:6139–49.
   PubMed Web of Science ®Google Scholar
• Anselmo AC, Mitragotri S. (2015). A review of clinical translation of inorganic nanoparticles. AAPS J 17:1041–54.
   PubMed Web of Science ®Google Scholar
• Dreaden EC, Alkilany AM, Huang X, et al. (2012). The golden age: gold nanoparticles for biomedicine. Chem Soc Rev 41:2740–79.
   PubMed Web of Science ®Google Scholar
• Jenkins SV, Muldoon TJ, Chen J. (2015). Plasmonic nanostructures for biomedical and sensing applications. In: Xiong Y, Lu X, eds. Metallic Nanostructures: from controlled synthesis to applications. Switzerland: Springer International Publishing, 133–173.
   Google Scholar
• Kobayashi H, Watanabe R, Choyke PL. (2013). Improving conventional enhanced permeability and retention (EPR) effects; what is the appropriate target? Theranostics 4:81–9.
   PubMed Web of Science ®Google Scholar
• Wilhelm S, Tavares AJ, Dai Q, et al. (2016). Analysis of nanoparticle delivery to tumours. Nat Rev Mater 1:16014. http://www.nature.com/articles/natrevmats201614#supplementary-information.
   Web of Science ®Google Scholar
• Huang X, Peng X, Wang Y, et al. (2010). A reexamination of active and passive tumor targeting by using rod-shaped gold nanocrystals and covalently conjugated peptide ligands. ACS Nano 4:5887–96.
   PubMed Web of Science ®Google Scholar
• Chattopadhyay N, Fonge H, Cai Z, et al. (2012). Role of antibody-mediated tumor targeting and route of administration in nanoparticle tumor accumulation in vivo. Mol Pharm 9:2168–79.
   PubMed Web of Science ®Google Scholar
• Sykes EA, Dai Q, Sarsons CD, et al. (2016). Tailoring nanoparticle designs to target cancer based on tumor pathophysiology. Proc Natl Acad Sci USA 113:E1142.
   PubMed Web of Science ®Google Scholar
• De Jong WH, Hagens WI, Krystek P, et al. (2008). Particle size-dependent organ distribution of gold nanoparticles after intravenous administration. Biomaterials 29:1912–19.
   PubMed Web of Science ®Google Scholar
• Albanese A, Tang PS, Chan WC. (2012). The effect of nanoparticle size, shape, and surface chemistry on biological systems. Annu Rev Biomed Eng 14:1–16.
   PubMed Web of Science ®Google Scholar
• Sykes EA, Chen J, Zheng G, Chan WC. (2014). Investigating the impact of nanoparticle size on active and passive tumor targeting efficiency. ACS Nano 8:5696–706.
   PubMed Web of Science ®Google Scholar
• Bazak R, Houri M, El Achy S, et al. (2015). Cancer active targeting by nanoparticles: a comprehensive review of literature. J Cancer Res Clin Oncol 141:769–84.
   PubMed Web of Science ®Google Scholar
• Oyewumi MO, Yokel RA, Jay M, et al. (2004). Comparison of cell uptake, biodistribution and tumor retention of folate-coated and PEG-coated gadolinium nanoparticles in tumor-bearing mice. J Control Release 95:613–26.
   PubMed Web of Science ®Google Scholar
• Wolfe T, Chatterjee D, Lee J, et al. (2015). Targeted gold nanoparticles enhance sensitization of prostate tumors to megavoltage radiation therapy in vivo. Nanomed: Nanotechnol Biol Med 11:1277–83.
   PubMed Web of Science ®Google Scholar
• Zelasko-Leon DC, Fuentes CM, Messersmith PB. (2015). MUC1-targeted cancer cell photothermal ablation using bioinspired gold nanorods. PLoS One 10:e0128756.
   PubMed Web of Science ®Google Scholar
• Meeker DG, Jenkins SV, Miller EK, et al. (2016). Synergistic photothermal and antibiotic killing of biofilm-associated Staphylococcus aureus using targeted antibiotic-loaded gold nanoconstructs. ACS Infect Dis 2:241–50.
   PubMed Web of Science ®Google Scholar
• Chen J, Glaus C, Laforest R, et al. (2010). Gold nanocages as photothermal transducers for cancer treatment. Small 6:811–17.
   PubMed Web of Science ®Google Scholar
• Chen J, Wang D, Xi J, et al. (2007). Immuno gold nanocages with tailored optical properties for targeted photothermal destruction of cancer cells. Nano Lett 7:1318–22.
   PubMed Web of Science ®Google Scholar
• Robinson R, Gerlach W, Ghandehari H. (2015). Comparative effect of gold nanorods and nanocages for prostate tumor hyperthermia. J Control Release 220:245–52.
   PubMed Web of Science ®Google Scholar
• Lisunova M, Dunklin JR, Jenkins SV, et al. (2015). The unusual visible photothermal response of free standing multilayered films based on plasmonic bimetallic nanocages. RSC Adv 5:15719–27.
   Web of Science ®Google Scholar
• Liu X, Cao J, Li H, et al. (2013). Mussel-inspired polydopamine: a biocompatible and ultrastable coating for nanoparticles in vivo. ACS Nano 7:9384–95.
   PubMed Web of Science ®Google Scholar
• Hong S, Kim KY, Wook HJ, et al. (2011). Attenuation of the in vivo toxicity of biomaterials by polydopamine surface modification. Nanomedicine (Lond) 6:793–801.
   PubMed Web of Science ®Google Scholar
• Cui J, Yan Y, Such GK, et al. (2012). Immobilization and intracellular delivery of an anticancer drug using mussel-inspired polydopamine capsules. Biomacromolecules 13:2225–8.
   PubMed Web of Science ®Google Scholar
• Ye Q, Zhou F, Liu W. (2011). Bioinspired catecholic chemistry for surface modification. Chem Soc Rev 40:4244–58.
   PubMed Web of Science ®Google Scholar
• Folkman J. (1971). Tumor angiogenesis: therapeutic implications. N Engl J Med 285:1182–6.
   PubMed Web of Science ®Google Scholar
• Denekamp J. (1982). Endothelial cell proliferation as a novel approach to targeting tumour therapy. Br J Cancer 45:136–9. PubMed PMID: PMC2010961.
   PubMed Web of Science ®Google Scholar
• Wagner SC, Ichim TE, Ma H, et al. (2015). Cancer anti-angiogenesis vaccines: is the tumor vasculature antigenically unique? J Translat Med 13:340.
   PubMed Web of Science ®Google Scholar
• Garcia-Barros M, Paris F, Cordon-Cardo C, et al. (2003). Tumor response to radiotherapy regulated by endothelial cell apoptosis. Science 300:1155–9.
   PubMed Web of Science ®Google Scholar
• Berbeco RI, Ngwa W, Makrigiorgos GM. (2011). Localized dose enhancement to tumor blood vessel endothelial cells via megavoltage X-rays and targeted gold nanoparticles: new potential for external beam radiotherapy. Int J Radiat Oncol Biol Phys 81:270–6.
   PubMed Web of Science ®Google Scholar
• Dings RP, Williams BW, Song CW, et al. (2005). Anginex synergizes with radiation therapy to inhibit tumor growth by radiosensitizing endothelial cells. Int J Cancer 115:312–19.
   PubMed Web of Science ®Google Scholar
• Denekamp J. (1990). Vascular attack as a therapeutic strategy for cancer. Cancer Metastasis Rev 9:267–82.
   PubMed Web of Science ®Google Scholar
• Koonce NA, Quick CM, Hardee ME, et al. (2015). Combination of gold nanoparticle-conjugated tumor necrosis factor-alpha and radiation therapy results in a synergistic antitumor response in murine carcinoma models. Int J Radiat Oncol Biol Phys 93:588–96.
   PubMed Web of Science ®Google Scholar
• Visaria RK, Griffin RJ, Williams BW, et al. (2006). Enhancement of tumor thermal therapy using gold nanoparticle-assisted tumor necrosis factor-alpha delivery. Mol Cancer Ther 5:1014–20.
   PubMed Web of Science ®Google Scholar
• Peiris PM, Deb P, Doolittle E, et al. (2015). Vascular targeting of a gold nanoparticle to breast cancer metastasis. J Pharm Sci 104:2600–10.
   PubMed Web of Science ®Google Scholar
• Shao J, Griffin RJ, Galanzha EI, et al. (2013). Photothermal nanodrugs: potential of TNF-gold nanospheres for cancer theranostics. Sci Rep 3:1293.
   PubMed Web of Science ®Google Scholar
• Thijssen VL, Postel R, Brandwijk RJ, et al. (2006). Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy. Proc Natl Acad Sci USA 103:15975–80.
   PubMed Web of Science ®Google Scholar
• Rabinovich GA. (2005). Galectin-1 as a potential cancer target. Br J Cancer 92:1188–92.
   PubMed Web of Science ®Google Scholar
• Liu FT, Rabinovich GA. (2005). Galectins as modulators of tumour progression. Nat Rev Cancer 5:29–41.
   PubMed Web of Science ®Google Scholar
• Upreti M, Jamshidi-Parsian A, Apana S, et al. (2013). Radiation-induced galectin-1 by endothelial cells: a promising molecular target for preferential drug delivery to the tumor vasculature. J Mol Med (Berl) 91:497–506.
   PubMed Web of Science ®Google Scholar
• Kuo P, Bratman SV, Shultz DB, et al. (2014). Galectin-1 mediates radiation-related lymphopenia and attenuates NSCLC radiation response. Clin Cancer Res 20:5558–69.
   PubMed Web of Science ®Google Scholar
• Dings RP, Van Laar ES, Loren M, et al. (2010). Inhibiting tumor growth by targeting tumor vasculature with galectin-1 antagonist anginex conjugated to the cytotoxic acylfulvene, 6-hydroxylpropylacylfulvene. Bioconjug Chem 21:20–7.
   PubMed Web of Science ®Google Scholar
• Dings RP, Van Laar ES, Webber J, et al. (2008). Ovarian tumor growth regression using a combination of vascular targeting agents anginex or topomimetic 0118 and the chemotherapeutic irofulven. Cancer Lett 265:270–80.
   PubMed Web of Science ®Google Scholar
• Griffin RJ, Koonce NA, Dings RP, et al. (2012). Microbeam radiation therapy alters vascular architecture and tumor oxygenation and is enhanced by a galectin-1 targeted anti-angiogenic peptide. Radiat Res 177:804–12.
   PubMed Web of Science ®Google Scholar
• Dings RP, van der Schaft DW, Hargittai B, et al. (2003). Anti-tumor activity of the novel angiogenesis inhibitor anginex. Cancer Lett 194:55–66.
   PubMed Web of Science ®Google Scholar
• Dings RP, Loren M, Heun H, et al. (2007). Scheduling of radiation with angiogenesis inhibitors Anginex and Avastin improves therapeutic outcome via vessel normalization. Clin Cancer Res 13:3395–402.
   PubMed Web of Science ®Google Scholar
• Dings RP, Yokoyama Y, Ramakrishnan S, et al. (2003). The designed angiostatic peptide anginex synergistically improves chemotherapy and antiangiogenesis therapy with angiostatin. Cancer Res 63:382–5.
   PubMed Web of Science ®Google Scholar
• Dings RP, Mayo KH. (2007). A journey in structure-based drug discovery: from designed peptides to protein surface topomimetics as antibiotic and antiangiogenic agents. Acc Chem Res 40:1057–65.
   PubMed Web of Science ®Google Scholar
• Dings RP, Arroyo MM, Lockwood NA, et al. (2003). Beta-sheet is the bioactive conformation of the anti-angiogenic anginex peptide. Biochem J 23:281–8.
   Google Scholar
• Skrabalak SE, Au L, Li X, Xia Y. (2007). Facile synthesis of Ag nanocubes and Au nanocages. Nat Protoc 2:2182–90.
   PubMed Web of Science ®Google Scholar
• Muñoz JL, García-Molina F, Varón R, et al. (2006). Calculating molar absorptivities for quinones: application to the measurement of tyrosinase activity. Anal Biochem 351:128–38.
   PubMed Web of Science ®Google Scholar
• van der Schaft DW, Dings RP, de Lussanet QG, et al. (2002). The designer anti-angiogenic peptide anginex targets tumor endothelial cells and inhibits tumor growth in animal models. FASEB J 16:1991–3.
   PubMed Web of Science ®Google Scholar
• Jenkins SV, Srivatsan A, Reynolds KY, et al. (2016). Understanding the interactions between porphyrin-containing photosensitizers and polymer-coated nanoparticles in model biological environments. J Coll Interf Sci 461:225–31.
   PubMed Web of Science ®Google Scholar
• Srivatsan A, Jenkins SV, Jeon M, et al. (2014). Gold nanocage-photosensitizer conjugates for dual-modal image-guided enhanced photodynamic therapy. Theranostics 4:163–74.
   PubMed Web of Science ®Google Scholar
• Storti P, Marchica V, Airoldi I, et al. (2016). Galectin-1 suppression delineates a new strategy to inhibit myeloma-induced angiogenesis and tumoral growth in vivo. Leukemia 30:2351–63.
   PubMed Web of Science ®Google Scholar
• Dalotto-Moreno T, Croci DO, Cerliani JP, et al. (2013). Targeting galectin-1 overcomes breast cancer-associated immunosuppression and prevents metastatic disease. Cancer Res 73:1107.
   PubMed Web of Science ®Google Scholar
• Shen J, Person MD, Zhu J, et al. (2004). Protein expression profiles in pancreatic adenocarcinoma compared with normal pancreatic tissue and tissue affected by pancreatitis as detected by two-dimensional gel electrophoresis and mass spectrometry. Cancer Res 64:9018.
   PubMed Web of Science ®Google Scholar
• Jenkins SV, Gohman TD, Miller EK, Chen J. (2015). Synthesis of hollow gold–silver alloyed nanoparticles: a “galvanic replacement” experiment for chemistry and engineering students. J Che Educ 92:1056–60.
   Web of Science ®Google Scholar
• Pang B, Yang X, Xia Y. (2016). Putting gold nanocages to work for optical imaging, controlled release and cancer theranostics. Nanomedicine 11:1715–28.
   PubMed Web of Science ®Google Scholar
• Piao J-G, Wang L, Gao F, et al. (2014). Erythrocyte membrane is an alternative coating to polyethylene glycol for prolonging the circulation lifetime of gold nanocages for photothermal therapy. ACS Nano 8:10414–25.
   PubMed Web of Science ®Google Scholar
• Fratoddi I, Venditti I, Cametti C, Russo MV. (2015). How toxic are gold nanoparticles? The state-of-the-art. Nano Res 8:1771–99.
   Web of Science ®Google Scholar
• Liebscher J, Mrówczyński R, Scheidt HA, et al. (2013). Structure of polydopamine: a never-ending story?. Langmuir 29:10539–48.
   PubMed Web of Science ®Google Scholar